Oh Hyun Ju, Kido Tatsuo, Lau Yun-Fai Chris
Department of Medicine, VA Medical Center, University of California, San Francisco, California, USA.
Mol Reprod Dev. 2007 Nov;74(11):1446-55. doi: 10.1002/mrd.20737.
SOX9 is a transcription factor that harbors a HMG box and plays critical roles in developmental processes including sex determination and chondrogenesis. Currently the regulation of its molecular activity is not well characterized. In the present study, we have identified PIAS1 as a regulator for SOX9 activity. Using the GST pull-down, co-immunoprecipitation, and co-localization methods in tissue culture cells and mouse embryonic tissues, we demonstrated that SOX9 interacts with PIAS1 in vitro and in vivo. PIAS1 enhanced the SUMOylation at lysine 396 of mouse SOX9. Mutant SOX9 with a conversion of lysine 396 to arginine had a distinct nuclear localization from SOX9 with covalently attached SUMO-1. Effects of SOX9 SUMOylation on its transcriptional activity were examined by reporter assays using Vanin-1 promoter and Col11a2 enhancer constructs. The lysine 396 to arginine conversion significantly increased the reporter gene activity, while covalent attachment of SUMO-1 to SOX9 by gene fusion dramatically compromised its transcriptional activity on the reporter gene. Effects of SOX9 interaction with PIAS1 on its transcriptional activity were examined by similar reporter assays. PIAS1 was able to repress both wild type SOX9 and SUMOylation-deficient SOX9-K396R, suggesting that SOX9 SUMOylation is not absolutely required for the repression by PIAS1. However, the repression was further enhanced by exogenous SUMO-1 while SUMO-ligase-deficient PIAS1 was not able to repress SOX9 activity. Thus, PIAS1 appears to repress SOX9 activity by at least two SUMO-ligase dependent mechanisms: (1) the SUMOylation of SOX9 and (2) SUMOylation of unknown factors associated with SOX9 and/or PIAS1.
SOX9是一种含有HMG盒的转录因子,在包括性别决定和软骨形成在内的发育过程中发挥关键作用。目前,其分子活性的调节机制尚未完全明确。在本研究中,我们鉴定出PIAS1是SOX9活性的调节因子。通过在组织培养细胞和小鼠胚胎组织中使用GST下拉、免疫共沉淀和共定位方法,我们证明了SOX9在体外和体内均与PIAS1相互作用。PIAS1增强了小鼠SOX9赖氨酸396位点的SUMO化修饰。将赖氨酸396突变为精氨酸的突变型SOX9与共价连接SUMO-1的SOX9具有不同的核定位。通过使用Vanin-1启动子和Col11a2增强子构建体的报告基因测定法,检测了SOX9 SUMO化修饰对其转录活性的影响。赖氨酸396突变为精氨酸显著增加了报告基因活性,而通过基因融合将SUMO-1共价连接到SOX9上则显著损害了其对报告基因的转录活性。通过类似的报告基因测定法,检测了SOX9与PIAS1相互作用对其转录活性的影响。PIAS1能够抑制野生型SOX9和SUMO化缺陷型SOX9-K396R,这表明PIAS1的抑制作用并非绝对依赖于SOX9的SUMO化修饰。然而,外源性SUMO-1进一步增强了这种抑制作用,而SUMO连接酶缺陷型PIAS1则无法抑制SOX9活性。因此,PIAS1似乎至少通过两种SUMO连接酶依赖性机制抑制SOX9活性:(1)SOX9的SUMO化修饰;(2)与SOX9和/或PIAS1相关的未知因子的SUMO化修饰。